Lishan Aklog M.D.
Net Worth

Last updated:

What is Lishan Aklog M.D. net worth?

The estimated net worth of Dr. Lishan Aklog M.D. is at least $12,843,040 as of 18 Mar 2021. He owns shares worth $489,640 as insider and has received compensation worth at least $12,353,400 in PAVmed Inc. and PAVmed Inc..

What is the salary of Lishan Aklog M.D.?

Dr. Lishan Aklog M.D. salary is $686,300 per year as Chairman & Chief Executive Officer in PAVmed Inc.. He also receives $686,300 as Chairman & Chief Executive Officer in PAVmed Inc..

How old is Lishan Aklog M.D.?

Dr. Lishan Aklog M.D. is 59 years old, born in 1966.

What stocks does Lishan Aklog M.D. currently own?

As insider, Dr. Lishan Aklog M.D. owns shares in 2 companies:

Company Title Shares Price per share Total value
PAVmed Inc. (PAVM) Chairman & Chief Executive Officer 1,105,913 $0.42 $465,036
PAVmed Inc. (PAVMW) Chairman & Chief Executive Officer 848,413 $0.03 $24,604

What does PAVmed Inc. do?

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics; NextVent single-use ventilators; FlexMO medical circulatory support cannulas; Veris cardiac monitors; DisappEAR resorbable pediatric ear tubes; Solys noninvasive glucose monitoring. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

PAVM logo
PAVM
PAVmed Inc.
$0.42

What does PAVmed Inc. do?

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.

PAVMW logo
PAVMW
PAVmed Inc.
$0.03

Lishan Aklog M.D. insider trading

PAVmed Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 7,500 N/A N/A
Purchase
Common Stock 30,000 $1.1 $32,850
Purchase
Common Stock 30,000 $1.18 $35,400
Purchase
Common Stock 950 N/A N/A
Purchase
Common Stock 601 N/A N/A
Purchase
Common Stock 2,600 N/A N/A
Purchase
Warrants 100 N/A N/A
Purchase
Common Stock 300 N/A N/A
Purchase
Common Stock 100 N/A N/A
Purchase
Warrants 200 N/A N/A
Purchase
Common Stock 300 N/A N/A
Purchase
Common Stock 400 N/A N/A
Purchase
Warrants 300 N/A N/A
Purchase
Common Stock 850 N/A N/A
Purchase
Warrants 200 N/A N/A
Purchase
Common Stock 899 N/A N/A
Purchase
Warrants 800 N/A N/A
Purchase
Common Stock 800 N/A N/A
Purchase
Warrants 200 $5 $1,000
Purchase
Warrants 200 N/A N/A
Purchase
Warrants 200 N/A N/A
Purchase
Common Stock 300 N/A N/A
Purchase
Warrants 1,700 N/A N/A
Purchase
Common Stock 1,600 N/A N/A
Purchase
Warrants 200 N/A N/A
Purchase
Common Stock 300 N/A N/A
Purchase
Warrants 1,200 N/A N/A
Purchase
Common Stock 1,412 N/A N/A
Purchase
Common Stock 900 N/A N/A
Purchase
Warrants 600 N/A N/A
Purchase
Common Stock 1,200 N/A N/A
Purchase
Common Stock 7,900 N/A N/A
Purchase
Common Stock 1,500 N/A N/A
Purchase
Common Stock 7,500 N/A N/A
Purchase
Common Stock 8,400 N/A N/A
Purchase
Warrants 200 N/A N/A
Purchase
Common Stock 1,800 N/A N/A
Purchase
Common Stock 1,885 N/A N/A
Purchase
Warrants 25,000 N/A N/A
Purchase
Common Stock 1,777 N/A N/A
Purchase
Common Stock 1,000 N/A N/A
Purchase
Common Stock 2,200 N/A N/A
Purchase
Warrants 300 N/A N/A
Purchase
Common Stock 900 N/A N/A
Purchase
Common Stock 1,400 N/A N/A
Purchase
Common Stock 1,000 $14 $13,998
Purchase
Common Stock 1,000 N/A N/A
Purchase
Common Stock 300 N/A N/A
Purchase
Common Stock 200 N/A N/A
Purchase
Warrants 200 N/A N/A
Purchase
Common Stock 800 N/A N/A
Purchase
Warrants 800 $8.75 $7,002
Purchase
Warrants 800 N/A N/A
Purchase
Common Stock 500 N/A N/A
Purchase
Warrants 300 N/A N/A
Purchase
Common Stock 400 N/A N/A
Purchase
Warrants 200 N/A N/A
Purchase
Warrants 350 N/A N/A
Purchase
Common Stock 500 N/A N/A
Purchase
Warrants 800 $8.08 $6,460
Purchase
Common Stock 1,000 N/A N/A
Purchase
Warrants 800 N/A N/A
Purchase
Common Stock 900 N/A N/A
Purchase
Common Stock 1,500 N/A N/A
Purchase
Common Stock 1,500 N/A N/A
Purchase
Common Stock 2,500 N/A N/A
Purchase
Common Stock 2,000 N/A N/A
Purchase
Common Stock 2,900 N/A N/A
Purchase
Common Stock 1,700 N/A N/A
Purchase
Common Stock 1,400 N/A N/A
Purchase
Common Stock 1,500 N/A N/A
Purchase
Common Stock 800 $5 $4,000
Purchase
Common Stock 800 N/A N/A

PAVmed Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 30,000 N/A N/A
Purchase
Common Stock 30,000 $1.18 $35,400
Purchase
Common Stock 950 N/A N/A
Purchase
Common Stock 601 N/A N/A
Purchase
Common Stock 2,600 N/A N/A
Purchase
Warrants 100 $6.66 $666
Purchase
Common Stock 300 N/A N/A
Purchase
Warrants 200 $5 $1,000
Purchase
Common Stock 100 $6.66 $666
Purchase
Common Stock 300 N/A N/A
Purchase
Common Stock 400 N/A N/A
Purchase
Warrants 300 N/A N/A
Purchase
Warrants 200 $5 $1,000
Purchase
Common Stock 850 N/A N/A
Purchase
Warrants 800 N/A N/A
Purchase
Common Stock 899 N/A N/A
Purchase
Common Stock 800 N/A N/A
Purchase
Warrants 200 $5 $1,000
Purchase
Common Stock 300 N/A N/A
Purchase
Warrants 200 N/A N/A
Purchase
Common Stock 1,600 N/A N/A
Purchase
Warrants 1,700 N/A N/A
Purchase
Warrants 200 N/A N/A
Purchase
Common Stock 300 N/A N/A
Purchase
Warrants 1,200 $5 $6,000
Purchase
Common Stock 1,412 N/A N/A
Purchase
Warrants 600 $5 $3,000
Purchase
Common Stock 900 N/A N/A
Purchase
Common Stock 1,200 N/A N/A
Purchase
Common Stock 7,900 N/A N/A
Purchase
Common Stock 1,500 N/A N/A
Purchase
Common Stock 7,500 N/A N/A
Purchase
Common Stock 8,400 N/A N/A
Purchase
Warrants 200 $5 $1,000
Purchase
Common Stock 1,800 N/A N/A
Purchase
Common Stock 1,885 $3.31 $6,247
Purchase
Warrants 25,000 N/A N/A
Purchase
Common Stock 1,777 $9.02 $16,036
Purchase
Common Stock 1,000 $9.53 $9,530
Purchase
Warrants 300 $5 $1,500
Purchase
Common Stock 2,200 $8.99 $19,767
Purchase
Common Stock 900 $9.93 $8,939
Purchase
Common Stock 1,400 $10.07 $14,097
Purchase
Common Stock 1,000 $14 $13,998
Purchase
Common Stock 300 $13.95 $4,186
Purchase
Common Stock 200 $14.45 $2,890
Purchase
Warrants 200 $14.45 $2,890
Purchase
Common Stock 800 $13.14 $10,515
Purchase
Warrants 800 $8.75 $7,002
Purchase
Warrants 300 $5 $1,500
Purchase
Common Stock 500 $13.79 $6,897
Purchase
Common Stock 400 $14.3 $5,720
Purchase
Warrants 200 $5 $1,000
Purchase
Warrants 350 N/A N/A
Purchase
Common Stock 500 $14.23 $7,113
Purchase
Warrants 800 $8.08 $6,460
Purchase
Common Stock 1,000 $9.63 $9,625
Purchase
Common Stock 900 N/A N/A
Purchase
Common Stock 1,500 $5 $7,500
Purchase
Common Stock 1,500 N/A N/A
Purchase
Common Stock 2,500 $5 $12,500
Purchase
Common Stock 2,000 N/A N/A
Purchase
Common Stock 2,900 $5 $14,500
Purchase
Common Stock 1,700 N/A N/A
Purchase
Common Stock 1,400 $5 $7,000
Purchase
Common Stock 1,500 N/A N/A
Purchase
Common Stock 800 $5 $4,000

PAVmed key executives

PAVmed Inc. executives and other stock owners filed with the SEC:

  • Dr. Brian J. deGuzman M.D. (60) Chief Medical Officer & Executive Vice President of Clinical Affairs
  • Dr. Lishan Aklog M.D. (59) Chairman & Chief Executive Officer
  • Mr. Dennis M. McGrath CPA (68) Pres, Chief Financial Officer & Corporation Sec.